Limited Time Offer. Become a Founder Member Now!

Nevada mandates BRCA gene testing coverage in health care plans

April 24, 2025 | House Bills - Introduced, House Bills, 2025 House and Senate Bills, Nevada Legislation Bills, Nevada


This article was created by AI summarizing key points discussed. AI makes mistakes, so for full details and context, please refer to the video of the full meeting. Please report any errors so we can fix them. Report an error »

Nevada mandates BRCA gene testing coverage in health care plans
Assembly Bill 522, introduced in the Nevada State Legislature on April 24, 2025, aims to enhance healthcare coverage for women by mandating that managed care organizations provide comprehensive benefits for screening, genetic counseling, and testing related to harmful mutations in the BRCA gene. This legislation addresses critical health issues, particularly the prevention and early detection of breast and ovarian cancers, which disproportionately affect women with BRCA mutations.

Key provisions of the bill stipulate that managed care organizations cannot impose higher deductibles, copayments, or waiting periods for these essential services. Additionally, the bill prohibits insurers from denying coverage or penalizing healthcare providers who offer these benefits. This approach seeks to eliminate financial barriers that may prevent women from accessing necessary genetic testing and counseling.

The introduction of AB 522 has sparked notable discussions among lawmakers and healthcare advocates. Proponents argue that the bill is a significant step toward improving women's health outcomes and reducing the long-term costs associated with untreated genetic conditions. Critics, however, express concerns about the potential financial impact on insurance providers and the broader healthcare system, fearing that mandated coverage could lead to increased premiums for all insured individuals.

Economically, the bill could have far-reaching implications. By facilitating early detection and preventive measures, it may ultimately reduce healthcare costs associated with advanced cancer treatments. Socially, the legislation aims to empower women by providing them with the necessary tools to make informed health decisions regarding their genetic risks.

As AB 522 moves through the legislative process, its supporters are optimistic about its potential to become law, viewing it as a crucial advancement in women's healthcare rights in Nevada. The bill's progress will be closely monitored, as its outcome could set a precedent for similar legislation in other states.

View Bill

This article is based on a bill currently being presented in the state government—explore the full text of the bill for a deeper understanding and compare it to the constitution

View Bill